MEDIUM confidence: 100% data completeness, but the composite (59) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $91 avg across 3 analysts.
Buy-rated share 33% → 27% over ~3 months (-7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.21 | $1.57 | +29.8% |
| Apr 2026 | $0.59 | $0.80 | +35.4% |
| Feb 2026 | $1.27 | $1.41 | +11.0% |
| Nov 2025 | $1.25 | $1.43 | +14.4% |
| Jul 2025 | $0.46 | $1.08 | +134.6% |
| Apr 2025 | $0.66 | $0.75 | +14.5% |
| Feb 2025 | $1.27 | $1.49 | +17.3% |
| Oct 2024 | $1.11 | $1.22 | +9.9% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15.3B— | $16.9B+10.9% | $15.8B-6.9% | $15.4B-2.6% | $15.1B-1.5% |
| EPS (dil.) | $10.16— | $-0.89-108.8% | $-2.07n/m | $1.95n/m | $2.65+35.9% |
| Free Cash Flow | $144M— | -$2.0B-1481.9% | $853Mn/m | $753M-11.7% | $688M-8.6% |
| Gross Margin | 33.2% | 24.2%-9.0pp | 26.0%+1.8pp | 29.9%+4.0pp | 29.9%-0.1pp |
| Operating Margin | 13.5% | 5.4%-8.2pp | 5.8%+0.4pp | 8.8%+3.0pp | 7.6%-1.2pp |
| Net Margin | 11.1% | -0.8%-11.9pp | -1.8%-1.0pp | 1.9%+3.6pp | 2.7%+0.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 2.6%/yr (revenue basis).
Base free cash flow $765M (avg FY2023–FY2025; latest year $688M) · equity value $15.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$105K over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 59 for SWK indicates a relatively neutral outlook, with the short-term score of 62 being slightly more favorable than the long-term score of 56. SWK scores high on momentum, driven by its +43% return over the past year and a bullish 50-day versus 200-day moving average trend. However, the stock's growth and profitability categories are more subdued, with revenue growth of -1.5% and an ROE near 7%, which weigh on the overall score, while its value category is supported by a P/E of 25.1 and P/B of 1.7.